Published financial brief
5051B
CATALENT PHARMA SOLUTIONS
- As of
- 2013-06-30
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
3 data notes
- Only 4 of 5 periods.
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
4 reported periods
| Metric | FY 20102010-06-30 | FY 20112011-06-30 | FY 20122012-06-30 | FY 20132013-06-30 |
|---|---|---|---|---|
| Financial statements | ||||
| RevenueUSD millions | —missing | 1,640.3 | 1,694.8 | 1,800.3 |
| Cost of goods soldUSD millions | —missing | 1,002.3 | 1,006.5 | 1,079.5 |
| Selling, general and administrative expenseUSD millions | —missing | 311.2 | 334 | 340.6 |
| Depreciation and amortizationUSD millions | —missing | 119.5 | 129.7 | 152.2 |
| Net incomeUSD millions | —missing | -43.4 | 0.9 | -47.9 |
| Operating profit (EBIT)USD millions | —missing | 207.3 | 224.6 | 228 |
| Income taxesUSD millions | —missing | 24.1 | 16.5 | 24.1 |
| Short-term debtUSD millions | —missing | 28.7 | 43.2 | 35 |
| Long-term debtUSD millions | —missing | 2,318.6 | 2,640.3 | 2,656.6 |
| Cash and equivalentsUSD millions | —missing | 205.1 | 139 | 106.4 |
| ReceivablesUSD millions | —missing | 274.8 | 338.3 | 358 |
| InventoryUSD millions | —missing | 150.7 | 130.4 | 136.7 |
| PayablesUSD millions | —missing | 129.1 | 134.2 | 150.8 |
| Net property, plant and equipmentUSD millions | —missing | 759.5 | 809.7 | 814.5 |
| Capital expenditureUSD millions | —missing | 92.7 | 104.2 | 122.5 |
| Operating cash flowUSD millions | —missing | 99.7 | 87.9 | 137.7 |
| Prepaid expensesUSD millions | —missing | 17 | 24.2 | 16.2 |
| AccrualsUSD millions | —missing | 163.6 | 180.3 | 156.6 |
| EBITDAUSD millions | —missing | 326.8 | 354.3 | 380.2 |
| Working capitalUSD millions | —missing | 338.6 | 265.4 | 267.6 |
| Working capital requirementUSD millions | —missing | 296.4 | 334.5 | 343.9 |
| Total debtUSD millions | —missing | 2,347.3 | 2,683.5 | 2,691.6 |
| Free cash flowUSD millions | —missing | 7 | -16.3 | 15.2 |
| Unlevered free cash flowUSD millions | —missing | 234.1 | 12.8 | 248.3 |
| Returns and ratios | ||||
| ROICratio | —missing | 6.6% | 0.7% | 6.4% |
| Pre-tax ROICratio | —missing | 6.6% | 6.2% | 6.4% |
| Effective tax rateratio | —missing | 0% | 88.7% | 0% |
| Revenue growthratio | —missing | —missing | 3.3% | 6.2% |
| EBIT / Revenueratio | —missing | 12.6% | 13.3% | 12.7% |
| Revenue / Invested capitalmultiple | —missing | 0.52× | 0.47× | 0.5× |
| Cogs Over Revenuesratio | —missing | 61.1% | 59.4% | 60% |
| Sga Over Revenuesratio | —missing | 19% | 19.7% | 18.9% |
| Da Over Revenuesratio | —missing | 7.3% | 7.7% | 8.5% |
| Nfa Over Revenuesratio | —missing | 46.3% | 47.8% | 45.2% |
| Wcr Over Revenuesratio | —missing | 18.1% | 19.7% | 19.1% |
| Debt Over Ebitdamultiple | —missing | 7.18× | 7.57× | 7.08× |
| St Debt Over Cashmultiple | —missing | 0.14× | 0.31× | 0.33× |
| Interest Over Ebitdamultiple | —missing | 0.51× | 0.52× | 0.53× |
| Interest Over Nocf Nicfmultiple | —missing | 23.64× | -11.24× | 13.37× |
| Nsf Over Wcrmultiple | —missing | -0.6× | -0.29× | -0.21× |
Ask this snapshot
Research assistant
5051B · annualSnapshot 3eb1c0cd
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000